Balyasny Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-964,985	Closed	-$17.8M	–	3065
2025 Q3	$17.8M	Buy	964,985 +100,889	+12%	+$1.62M	0.04%	767
2025 Q2	$11.2M	Sell	864,096 -74,094	-8%	-$876K	0.03%	917
2025 Q1	$9.94M	Buy	938,190 +389,429	+71%	+$6.18M	0.02%	918
2024 Q4	$9.31M	Buy	+548,761	New	+$10.3M	0.02%	991
2024 Q3	–	Sell	-41,947	Closed	-$1.02M	–	2723
2024 Q2	$1.02M	Buy	+41,947	New	+$1.27M	﹤0.01%	1779
2023 Q2	–	Sell	-107,653	Closed	-$2.58M	–	2254
2023 Q1	$2.58M	Sell	107,653 -896,582	-89%	-$16.1M	0.01%	1367
2022 Q4	$17M	Buy	1,004,235 +664,852	+196%	+$11.6M	0.06%	547
2022 Q3	$5.03M	Buy	339,383 +328,574	+3,040%	+$5.51M	0.02%	992
2022 Q2	$170K	Buy	+10,809	New	+$212K	﹤0.01%	2221
2020 Q4	–	Sell	-26,628	Closed	-$1.14M	–	1306
2020 Q3	$1.14M	Sell	26,628 -66,750	-71%	-$3.31M	0.01%	963
2020 Q2	$4.36M	Buy	+93,378	New	+$3.22M	0.05%	550
2016 Q2	–	Sell	-42,283	Closed	-$1.12M	–	1157
2016 Q1	$1.12M	Sell	42,283 -62,761	-60%	-$2.13M	0.01%	759
2015 Q4	$4.62M	Buy	105,044 +73,619	+234%	+$3.31M	0.04%	511
2015 Q3	$1.33M	Buy	31,425 +4,429	+16%	+$233K	0.01%	706
2015 Q2	$1.24M	Buy	+26,996	New	+$1.24M	0.01%	788